BPCA
BIIB icon

Bank Pictet & Cie (Asia)’s Biogen BIIB Stock Holding History

Bank Pictet & Cie (Asia)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$335K Hold
1,444
– – 0.02% 83
2024
Q1 		$311K Sell
1,444
-3,639
-72% -$852K 0.02% 90
2023
Q4 		$1.32M Hold
5,083
– – 0.33% 66
2023
Q3 		$1.31M Buy
5,083
+1,259
+33% +$337K 0.39% 53
2023
Q2 		$1.09M Hold
3,824
– – 0.32% 71
2023
Q1 		$1.06M Sell
3,824
-41
-1% -$11.3K 0.36% 69
2022
Q4 		$1.07M Buy
3,865
+658
+21% +$186K 0.38% 62
2022
Q3 		$856K Sell
3,207
-2,640
-45% -$561K 0.34% 58
2022
Q2 		$1.19M Sell
5,847
-1,164
-17% -$238K 0.4% 41
2022
Q1 		$1.48M Buy
7,011
+1,597
+29% +$347K 0.4% 49
2021
Q4 		$1.3M Buy
5,414
+1,546
+40% +$398K 0.31% 68
2021
Q3 		$1.09M Buy
3,868
+276
+8% +$90.5K 0.3% 70
2021
Q2 		$1.24M Sell
3,592
-1,124
-24% -$341K 0.35% 64
2021
Q1 		$1.32M Buy
4,716
+1,577
+50% +$425K 0.41% 49
2020
Q4 		$769K Hold
3,139
– – 0.24% 74
2020
Q3 		$890K Sell
3,139
-69
-2% -$19.2K 0.34% 61
2020
Q2 		$858K Hold
3,208
– – 0.37% 54
2020
Q1 		$1.01M Sell
3,208
-628
-16% -$191K 0.49% 31
2019
Q4 		$1.14M Sell
3,836
-16
-0.4% -$4.44K 0.49% 32
2019
Q3 		$897K Hold
3,852
– – 0.4% 44
2019
Q2 		$901K Hold
3,852
– – 0.41% 43
2019
Q1 		$911K Buy
3,852
+1,450
+60% +$457K 0.43% 38
2018
Q4 		$723K Hold
2,402
– – 0.39% 51
2018
Q3 		$849K Sell
2,402
-626
-21% -$216K 0.39% 49
2018
Q2 		$879K Buy
+3,028
New +$851K 0.4% 68
2015
Q3 		– Sell
-760
Closed -$307K – 43
2015
Q2 		$307K Hold
760
– – 1.04% 23
2015
Q1 		$321K Buy
+760
New +$300K 0.24% 54

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank Pictet & Cie (Asia)'s BIIB Position: Q2 2024 in Review

Bank Pictet & Cie (Asia) held its Biogen (BIIB) position steady in Q2 2024 at 1,444 shares worth $335K. The position accounts for 0.02% of the portfolio, ranked #83.

Bank Pictet & Cie (Asia) first reported a position in BIIB in Q1 2015 and has held it in 27 quarters since. The position peaked at $1.48M in Q1 2022. 944 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Bank Pictet & Cie (Asia) held 1,444 shares of Biogen worth $335K as of Q2 2024.
  • Bank Pictet & Cie (Asia) left its Biogen share count unchanged in Q2 2024.
  • Biogen made up 0.02% of Bank Pictet & Cie (Asia)'s portfolio in Q2 2024, its #83 holding.
  • Bank Pictet & Cie (Asia) first reported a position in Biogen in Q1 2015 and has held it in 27 quarters since.
  • Bank Pictet & Cie (Asia)'s Biogen position peaked at $1.48M in Q1 2022.
  • 944 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2024, filed 16 Jul 2024.